BEAD Study

Study Type

Cognitive Impairment & Alzheimer's Disease

Study Purpose

The BEAD research study will evaluate a study drug and its effect on patients living with early Alzheimer’s disease.

The study will assess if the study drug is able to help slow down the disease progression. Researchers will also evaluate the drug’s safety and how well participants tolerate the medication.

About the Study

Study participants and their partners/caregivers will undergo a series of visits to Pennington Biomedical for assessment and observation. 

Members of the study team will remain in contact with participants throughout the study to ensure they are taking the medication as instructed, as well as to discuss any reactions to the drug.

Study Design

Total number of visits required for participants in this study:

  • Up to 5 screening visits
  • 14 study visits

Study Procedures:

  • Health assessment/vital signs (blood pressure, pulse, etc.)
  • Medical history
  • Questionnaires
  • Memory and thinking skills test
  • Physical and neurological examinations
  • Test for heart health (ECG)
  • Imaging (MRI)
  • Blood tests
  • Urine collection
  • PET Scan or Lumbar Puncture

Study Qualifications

To qualify, participants in this study should:

  • Be between the ages of 50-85 years old
  • Meet the criteria for Mild Cognitive Impairment or Mild Alzheimer’s Disease as determined at the screening visit.
  • Have a clear history of cognitive (memory) decline over at least one year.
  • Have a trial partner/caregiver to attend all study visits with the participant and be able to answer questions about the participant.

Study Duration

Participation in this study will last up to 30 months.


Compensation of up to $1,850 is offered for the completion of this study.

Study Contact

Interested volunteers may call 225-763-2973 or email


English Calculation
Enter Your Weight: 
Enter Your Height: 
 ft.  in.
Your BMI: